rs1001792

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003842.5(TNFRSF10B):​c.145-446A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 151,974 control chromosomes in the GnomAD database, including 16,692 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 16692 hom., cov: 32)

Consequence

TNFRSF10B
NM_003842.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.02

Publications

6 publications found
Variant links:
Genes affected
TNFRSF10B (HGNC:11905): (TNF receptor superfamily member 10b) The protein encoded by this gene is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. Two transcript variants encoding different isoforms and one non-coding transcript have been found for this gene. [provided by RefSeq, Mar 2009]
TNFRSF10B Gene-Disease associations (from GenCC):
  • head and neck squamous cell carcinoma
    Inheritance: AR, AD, Unknown Classification: LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003842.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003842.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFRSF10B
NM_003842.5
MANE Select
c.145-446A>G
intron
N/ANP_003833.4
TNFRSF10B
NM_147187.3
c.145-446A>G
intron
N/ANP_671716.2O14763-2
TNFRSF10B
NR_027140.2
n.282-12817A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFRSF10B
ENST00000276431.9
TSL:1 MANE Select
c.145-446A>G
intron
N/AENSP00000276431.4O14763-1
TNFRSF10B
ENST00000347739.3
TSL:1
c.145-446A>G
intron
N/AENSP00000317859.3O14763-2
TNFRSF10B
ENST00000931215.1
c.145-446A>G
intron
N/AENSP00000601274.1

Frequencies

GnomAD3 genomes
AF:
0.427
AC:
64899
AN:
151856
Hom.:
16657
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.721
Gnomad AMI
AF:
0.281
Gnomad AMR
AF:
0.282
Gnomad ASJ
AF:
0.360
Gnomad EAS
AF:
0.274
Gnomad SAS
AF:
0.245
Gnomad FIN
AF:
0.369
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.408
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.428
AC:
64984
AN:
151974
Hom.:
16692
Cov.:
32
AF XY:
0.424
AC XY:
31456
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.721
AC:
29908
AN:
41454
American (AMR)
AF:
0.282
AC:
4302
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
1245
AN:
3462
East Asian (EAS)
AF:
0.274
AC:
1414
AN:
5160
South Asian (SAS)
AF:
0.246
AC:
1186
AN:
4820
European-Finnish (FIN)
AF:
0.369
AC:
3893
AN:
10550
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.321
AC:
21818
AN:
67958
Other (OTH)
AF:
0.404
AC:
852
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1672
3345
5017
6690
8362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.350
Hom.:
41381
Bravo
AF:
0.432
Asia WGS
AF:
0.293
AC:
1018
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
4.0
DANN
Benign
0.62
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1001792;
hg19: chr8-22901202;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.